Ledger.Open graph →
SEC Form D · Amendment · filed May 29, 2018

Kleo Pharmaceuticals, Inc

Offering
—
Sold
$13.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David Spiegel · New Haven, CTExec · DirectorRoy Prieb · New Haven, CTExec · DirectorJohn W. Childs · Waltham, MADirectorDouglas G. Manion · New Haven, CTExecDeclan Doogan · Palm Coast, FLDirectorCharles G. Drake · New York, NYDirectorJoel Davidson · Luxembourg, LuxembourgExecTimothy Davenport · Tysons, VADirectorMatthew Boehm · Tysons, VAExec · DirectorJoanne J. Fitzgerald · Luxembourg, LuxembourgExec · DirectorCecelia D. Noreen · Lopez Island, WADirectorCorson Ellis · Tysons, VADirectorJennifer D. Schneider · Mountain View, CADirectorAndrew D. Page · Mountain View, CAExec · DirectorJoe D. Carey · Mountain View, CADirectorErica J. Palsis · Mountain View, CADirectorDave D. Engberg · Mountain View, CAExec · DirectorJody Flaws · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗